Publications:131
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Douglas A Tremblay, MD
Hematology-Oncology
About Me
Douglas Tremblay, MD is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Tremblay completed fellowship and residency training at Mount Sinai where he served as both Chief Fellow and Chief Resident. His clinical and translational research focus is on hematologic malignancies, particularly myelodysplastic/myeloproliferative overlap syndromes including chronic myelomonocytic leukemia (CMML) as well as myeloproliferative neoplasms (MPNs) and acute myeloid leukemia. Dr. Tremblay is the Principal Investigator (PI) on numerous investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Additionally, he is a participant in the American Society of Hematology Clinical Research Training Institute and holds multiple administrative roles at Mount Sinai.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Anemia
- Chronic Myelocytic Leukemia
- Essential Thrombocythemia
- Leukemia
- Myelodysplastic Syndromes
- Myelofibrosis
- Myeloproliferative Disorders
- Myeloproliferative Neoplasms (MPN)
- Polycythemia Vera
- Primary Polycythemia
Education
MD, Albert Einstein College of Medicine
Residency, Internal Medicine
Mount Sinai Hospital
Residency, Hospital Medicine
Mount Sinai Hospital
Fellowship, Hematology & Oncology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients. James Fan Wu, Erin Jay G. Feliciano, Angelica Singh, Douglas Tremblay, Muhammad Bilal Abid, Edward Christopher Dee. Leukemia
- Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a practical guide to diagnosis and management. Douglas Tremblay, Robert P. Hasserjian, Raajit K. Rampal. Leukemia
- Diagnosis and Treatment of Polycythemia Vera - Reply. Douglas Tremblay. JAMA - Journal of the American Medical Association
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Tremblay during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- GSK plc.
- Real CME
- Sierra Oncology
- Primum
- Swedish Orphan Biovitrum AB
- MPN Research Foundation
- Geron Corporation
- PharmaEssentia
- Novartis Pharmaceutical Corporation
- AbbVie Inc.
- Cogent Biosciences
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.